Legend Biotech Corp. (LEGN) PT Raised to $86 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Legend Biotech (LEGN) Tops Q1 EPS by 3c
May 13, 2024 7:01 AM EDTLegend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $93.99 million versus the consensus estimate of $143.81 million.
For earnings history and earnings-related data on Legend Biotech (LEGN) click here.
... More


